/
/
/

Ganga Pharmaceuticals Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Mar 2018Sep 2017Mar 2017Sep 2016Mar 2016
₹2 Cr₹1 Cr₹1 Cr₹1 Cr₹2 Cr
₹7 L₹7 L₹72 L₹7 L₹0
₹2 Cr₹1 Cr₹2 Cr₹1 Cr₹2 Cr
₹2 Cr₹1 Cr₹2 Cr₹1 Cr₹1 Cr
₹29 L₹18 L₹22 L₹24 L₹19 L
₹14 L₹14 L₹16 L₹16 L₹17 L
₹11 L₹1 L₹7 L₹4 L₹70,000
₹9 L₹1 L₹5 L₹2 L₹20,000

Share Price Live Stats

Open (₹)0.00
Volume (₹)0.00
High (₹)0.00
Upper Circuit14.40
Low (₹)0.00
Lower Circuit9.60
Prev Close12.00
52W High (₹)13.97
Price12.00
52W Low (₹)9.35

Share Market Cap & Key Ratios Overview

M.Cap (₹)7.09 Cr
Div. Yield (%)0.00
PE Ratio89.76
Debt to Equity0.22
Price to Book0.76
Book Value13.46
EPS (TTM)0.13
Face Value10.00
ROE (%)1.22

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMA-ANSE
DIVISLAB-ANSE
TORNTPHARM-ANSE
ZYDUSLIFE-ANSE
CIPLA-ANSE
LAURUSLABS-ANSE
LUPIN-ANSE
MANKIND-ANSE
DRREDDY-ANSE
AUROPHARMA-ANSE
GANGAPHARM-MNSE
LTP
1W Low
1W High
Market cap (₹)
1899-21.1 (-1.10%)
1895
1964.85
4,56,833Cr
9100-169 (-1.82%)
9051.85
9296
2,45,426Cr
4850-185 (-3.67%)
4822.25
5049
1,87,320Cr
1121-66 (-5.56%)
1121
1191.45
1,13,217Cr
1385-33 (-2.33%)
1375.85
1426.20
1,12,212Cr
1840-95.3 (-4.92%)
1812
1947.90
1,01,155Cr
2111-64 (-2.94%)
2104.40
2209
97,626Cr
2328.55-58.85 (-2.47%)
2321
2407.40
96,859Cr
1154-23.8 (-2.02%)
1154
1179.90
96,406Cr
1653.3+3.3 (0.20%)
1623.05
1706.70
93,614Cr
12+0 (0.00%)
12
12
7Cr

Key Highlights of Ganga Pharmaceuticals Ltd’s P&L

In 2025-03-31, Ganga Pharmaceuticals Ltd reported total revenue of ₹2.64Cr, compared with ₹2.74Cr in 2024-03-31, reflecting Ganga Pharmaceuticals Ltd turnover.

Depreciation was ₹4.65Lakh and finance costs were ₹17.85Lakh in 2025-03-31

Profit Before Tax (PBT) has been ₹9.47Lakh in 2025-03-31 as compared to ₹6.33Lakh in 2024-03-31.

Net Profit (PAT) was ₹7.9Lakh in 2025-03-31 compared with ₹4.66Lakh in 2024-03-31.

Earnings per share (EPS) were ₹0.16 in 2025-03-31, compared with ₹0.10 in 2024-03-31.